Literature DB >> 12605262

Endoscopically controlled erbium:YAG goniopuncture versus trabeculectomy: effect on intraocular pressure in combination with cataract surgery.

Nicolas Feltgen1, Heiko Mueller, Beat Ott, Martin Frenz, Jens Funk.   

Abstract

PURPOSE: . To compare the efficacy of endoscopic erbium:YAG laser goniopuncture in glaucoma treatment to trabeculectomy, both methods as adjuncts to cataract surgery.
METHODS: . Fifty-nine eyes of 59 glaucoma patients with coexistent cataract were treated by phacoemulsification and endoscopic Er:YAG goniopuncture in a combined fashion. The primary study endpoints were intraocular pressure (IOP), number of antiglaucomatous drugs, postoperative complications, hospitalisation time and visual acuity at 1 year after surgery. To date, 24 eyes have finished the 1-year follow-up. This prospective treatment arm was compared to a retrospective inclusion-matched control group treated by trabeculectomy and cataract surgery in a single procedure.
RESULTS: . In the laser-treated group, the mean IOP dropped by 30% from 23.4+/-3.7 mmHg to 16.3+/-6 mmHg ( P<0.0001) after 12 months. Without reoperation, treatment was successful in 71% of these eyes. In the control group, the IOP decreased by 33.5% from 22.7+/-3.3 mmHg to 15.1+/-3.8 mmHg ( P<0.0001). The success rate without reoperation was 46%. The number of antiglaucomatous drugs needed decreased from 1.48+/-0.95 to 0.48+/-0.7 ( P<0.0001) in the laser-treated group and from 2.0+/-0.9 to 0.39+/-0.6 ( P<0.0001) in the control group. Postoperative complications were found more frequently in the control group ( P<0.0001). Hospitalisation was shorter in the laser group ( P<0.0001). Postoperative visual acuity was lower in the control group ( P=0.004).
CONCLUSION: . Combined Er:YAG goniopuncture and cataract surgery lowers the IOP to an extent comparable to combined trabeculectomy and cataract surgery. Due to fewer postoperative complications, Er:YAG goniopuncture seems to be superior to standard fistulation surgery as the primary approach within the first year.

Entities:  

Mesh:

Year:  2003        PMID: 12605262     DOI: 10.1007/s00417-002-0557-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  Excimer laser trabeculotomy: a new, minimally invasive procedure for patients with glaucoma.

Authors:  Sonja Wilmsmeyer; Heiko Philippin; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-19       Impact factor: 3.117

2.  [Combined cataract and glaucoma surgery. Trabeculectomy vs Erb:YAG goniotomy].

Authors:  S Beuerle; H Philippin; J Funk
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

Review 3.  [Excimer laser trabeculotomy: minimally invasive glaucoma surgery].

Authors:  S Herdener; M Pache
Journal:  Ophthalmologe       Date:  2007-08       Impact factor: 1.059

Review 4.  Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery.

Authors:  Kevin Kaplowitz; Joel S Schuman; Nils A Loewen
Journal:  Br J Ophthalmol       Date:  2013-12-12       Impact factor: 4.638

5.  Combined cataract and glaucoma surgery: endoscope-controlled erbium:YAG-laser goniotomy versus trabeculectomy.

Authors:  Heiko Philippin; Sonja Wilmsmeyer; Nicolas Feltgen; Thomas Ness; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-02       Impact factor: 3.117

Review 6.  [Trabecular meshwork bypass surgery for glaucoma].

Authors:  T S Dietlein; A Schild; A Rosentreter; J F Jordan; G K Krieglstein
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

7.  [Combined glaucoma-cataract surgery].

Authors:  F Grehn; T Klink
Journal:  Ophthalmologe       Date:  2004-05-27       Impact factor: 1.059

Review 8.  Prospective Studies of Minimally Invasive Glaucoma Surgeries: Systematic Review and Quality Assessment.

Authors:  Jullia A Rosdahl; Divakar Gupta
Journal:  Clin Ophthalmol       Date:  2020-01-24

Review 9.  Intraocular endoscopy: A review.

Authors:  Vivek Pravin Dave; Mudit Tyagi; Raja Narayanan; Rajeev Reddy Pappuru
Journal:  Indian J Ophthalmol       Date:  2021-01       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.